Negative Pressure Wound Therapy Market - Growth, Trends, COVID-19 Impact, and Forecasts (2022 - 2027)

Market Overview

The negative pressure wound therapy market is projected to register a CAGR of 5.7% during the forecast period (2022-2027) with a market size of approximately, USD 3,325.96 million in 2021 and estimated to reach USD 4,498.93 million by 2027.

The COVID-19 pandemic has been continuing to transform the growth of various markets, and the immediate impact of the outbreak is varied. Most of the wounds are caused by road accidents and transport injuries. This was the significant driving element for the market. With the lockdown that was placed globally in the initial part of the pandemic public transport being canceled, and people not getting on roads like before, there was a drastic decrease in the number of accidents and injuries. As per the article published in the Wound Repair and Regeneration Journal in 2021, there was a paradigm shift in wound care toward hybrid telemedicine and home healthcare model to keep patients at home and reduce the number of in-person clinic visits and hospitalizations, except for serious cases like chronic limb-threatening ischemia. In the post-pandemic era, telemedicine and home care will probably still be used and even get better. Hence, all the factors mentioned above showed that COVID-19 had a notable impact on the negative pressure wound therapy market.

Negative pressure wound therapy (NPWT) is the most preferred choice of treatment, especially for deep acute wounds and persistent chronic wounds including leg ulcers. Some of the factors that are driving the overall market growth are the increasing number of accidents and traumatic events, rising chronic wounds such as diabetic foot ulcers, and technological advancements in NPWT devices.

Chronic wounds lead to complications, such as infection, ulceration, and insufficient blood supply, thus, increasing the wound healing period. Most common chronic wounds include venous ulcers, diabetic foot ulcers, and pressure ulcers. As per the 2022 update from the International Diabetic Federation (IDF), approximately 537 million adults (20-79 years) are living with diabetes. The total number of people living with diabetes is projected to rise to 643 million by 2030 and 783 million by 2045. Moreover, as per the IDF 2021 report, diabetic foot ulcers were affected by 40 to 60 million people globally. As a result, the market is likely to grow due to the increased prevalence of diabetic foot ulcers.

As per the 2022 update from the Mission Regional Medical Center, around 6.7 million people are living with chronic wounds and that number isexpected to grow by more than 2% in the next decade. Chronic wounds represent a cost of more than USD 50 billion to the health care system. Most clinical trials have shown the effectiveness of this therapy in the treatment of superficial wounds. Moreover, the localized use of negative pressure wound therapy in infected wounds offers advantages, such as wound drainage, angiogenesis stimulation, proteinase excretion, and decreased local and systemic bacterial load. A study published in 2020 under the title "Combination therapy of oxidised regenerated cellulose/collagen/silver dressings with negative pressure wound therapy for coverage of exposed critical structures in complex lower-extremity wounds" in the International Wound Journal, stated that silver dressings applied to negative pressure wound care prevent infection.Thus, due to the above-mentioned factors, the negative pressure wound therapy market is expected to grow at a significant rate during the forecast period. 

However high cost of devices and treatment can restrain the market growth.

Scope of the Report

As per the scope of this report, Negative-pressure wound therapy (NPWT) is a therapeutic technique that uses a suction dressing to remove excess exudation and promote healing in acute or chronic wounds and second-and third-degree burns. The Negative Pressure Wound Therapy Market is segmented by Product (Reusable Device, and Single-use Device), Wound Type (Diabetic Foot Ulcer, Pressure Ulcer, Venous Leg Ulcer, Burn Wounds, and Others), End-user (Hospitals, Homecare, Other End Users), and Geography (North America, Europe, Asia-Pacific, Middle East, and Africa, and South America). The market report also covers the estimated market sizes and trends for 17 different countries across major regions, globally The report offers the value (in USD million) for the above segments.

Report scope can be customized per your requirements. Click here.

Key Market Trends

Diabetic Foot Ulcers are Expected to Hold a Major Market Share in the Negative Pressure Wound Therapy Market.

A diabetic foot ulcer is an open sore or wound that occurs in approximately 15% of patients with diabetes and is commonly located on the bottom of the foot. The use of negative pressure wound therapy (NPWT) was found to be an effective initial wound therapy to achieve faster wound bed granulation in diabetic foot ulcers. Due to the increased application of NPWT in diabetic foot ulcers, this segment is expected to boost the market growth during the forecast period.

Moreover, Diabetic Foot Ulcers (DFU) is one of the most common complications associated with Diabetes and are posing a burden on several countries across the globe. According to the International Diabetic Federation (IDF) 2020 update, diabetic foot, and lower limb complications are severe and chronic and they affect 40 to 60 million people with diabetes globally. Several studies have revealed that NPWT is helpful in reducing the time it takes wounds to heal. Faster wound healing results in an overall decrease in hospitalization and avoids the additional morbidity of chronic wounds. Owing to many people with diabetic foot ulcers globally, there is a growing demand for negative pressure wound therapy devices, as it is one of the most efficacious, safe, and cost-effective methods of treating diabetic foot ulcers.

Furthermore, diabetic foot ulcers impose a substantial burden on public and private payers in the United States, doubling care costs per patient compared with diabetic patients without foot ulcers. The average annual expenditure of diabetic foot care in the United States is around USD 8,659 per patient and the total medical cost for the management of diabetic foot disease in the United States ranges from USD 9 to USD 13 billion, in addition to the cost for management of diabetes mellitus alone as per the data published in the Elsevier journal in 2022.

Hence, due to the efficacy of negative pressure wound therapy in healing diabetic foot ulcers in less time, the demand for negative pressure wound therapy is increasing despite its high price of it. Adding to that, the rising incidence and prevalence of diabetic foot ulcers across the globe are fueling the segment growth.

To understand key trends, Download Sample Report